Ekso Bionics Holdings GAAP EPS of -$0.23, revenue of $4.1M

09:36pm, Thursday, 24'th Feb 2022 Seeking Alpha
Ekso Bionics Holdings press release (EKSO): Q4 GAAP EPS of -$0.23.Revenue of $4.1M (+82.2% Y/Y).Cash on hand at December 31, 2021 was $40.4 million, compared to $12.9 million at…
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2021 after the close of trading on Thursday, February 24, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today a

Ekso Bionics'' CEO Jack Peurach steps down

09:05pm, Friday, 21'st Jan 2022 Seeking Alpha
Ekso Bionics (EKSO) said CEO Jack Peurach decided to leave the firm effective Jan. 21 to pursue other endeavors.Peurach also stepped down from EKSO''s board effective Jan. 21.Effective Jan

Ekso Bionics Announces Leadership Transition

09:01pm, Friday, 21'st Jan 2022 GlobeNewswire Inc.
Board Member Steven Sherman to be Appointed CEO

Ekso Bionics Holdings Inc Shares Near 52-Week Low - Market Mover

05:26am, Saturday, 15'th Jan 2022 Kwhen Finance
Ekso Bionics Holdings Inc (EKSO) shares closed today at 1.6% above its 52 week low of $2.49, giving the company a market cap of $32M. The stock is currently down 4.2% year-to-date, down 71.4% over the past 12 months, and down 95.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 77.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.9% lower than its 5-day moving average, 8.2% lower than its 20-day moving average, and 31.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -29.9% The company's stock price performance over the past 12 months lags the peer average by 211.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Ekso Bionics Holdings Inc (EKSO) shares closed 1.6% lower than its previous 52 week low, giving the company a market cap of $33M. The stock is currently up 0.8% year-to-date, down 61.4% over the past 12 months, and down 95.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 68.8% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -111.9% The company's stock price performance over the past 12 months lags the peer average by 394.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Ekso Bionics <> estimates record Q4 revenues in the range of $3.9 million to $4.1 million vs
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that mana
Ekso Bionics Holdings Inc (EKSO) shares closed 4.6% lower than its previous 52 week low, giving the company a market cap of $35M. The stock is currently down 53.8% year-to-date, down 59.5% over the past 12 months, and down 95.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.9%. Trading Activity Trading volume this week was 97.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -646.8% The company's stock price performance over the past 12 months lags the peer average by -800.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Ekso Bionics Appoints Corinna E. Lathan, Ph.D. to its Board of Directors

09:05pm, Tuesday, 28'th Dec 2021 GlobeNewswire Inc.
RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today

Ekso Bionics announces EksoNR multi-unit order

10:42pm, Thursday, 16'th Dec 2021 Seeking Alpha
- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -
- Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -
State Street Corp purchased a new position in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,780 shares of the companys stock, valued at approximately $76,000. Other institutional investors have also recently added to or reduced []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE